NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Small company capital formation issues; capital markets reform to encourage more IPOs, including disclosure of material short positions, venture exchanges, issues related to shareholder proposals, improving research coverage for small companies; Dodd-Frank regulatory issues including: revising the definition of venture capital fund for purposes of fund registration, Volcker Rule; blockchain regulatory and policy issues, including the Token Taxonomy Act H.R. 2144 and FinCEN rule regarding convertible virtual currencies; Implementation of the Foreign Investment Risk Review Modernization Act (FIRRMA); Developing and Empowering our Aspiring Leaders (DEAL) Act H.R. 8603; Fostering Innovation Act S. 452, H.R. 3886; Amendment to Accelerated Filer and Large Accelerated Filer definition; Beneficial ownership legislation including Corporate Transparency Act, H.R. 2513/S. 1978 and Illicit Cash Act, S. 2563; Private Securities Transparency and Reform Act; Managed Stablecoins are Securities Act H.R. 5197; Helping Startups Continue to Grow Act HR 4918; SEC proposal to modernize advertising and cash solicitation rules; Issues related to Coronavirus Aid, Relief, and Economic Security Act; Main Street Loan Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Copyright/Patent/Trademark CPT
Various patent litigation reform issues that impact investment in the startup ecosystem; STRONGER Patents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY New | — |
| CHARLOTTE SAVERCOOL | — |
Energy/Nuclear ENG
Cleantech energy policy issues, including energy innovation tax issues; ARPA-E; Energy and Water Appropriations; Energy Sector Innovation Credit Act HR 7196
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Taxation/Internal Revenue Code TAX
Issues related to the Tax Cuts and Jobs Act; Section 1061 regulations; capital gains tax policy; Carried Interest Fairness Act, H.R. 1735/S. 781; Ending the Carried Interest Loophole Act, S. 1639; carried interest capital gains; partnership tax policy; tax policy that encourages new company formation including: R&D credit, Section 1202, Section 382, stock options, medical device tax, tax extenders, opportunity zones, energy innovation tax issues, including the Energy Sector Innovation Credit Act HR 7196; Research & Development Tax Credit Expansion Act, S. 2207; CEO and Worker Pension Fairness Act; Families First Coronavirus Response Act; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Issues related to the Phase IV economic relief package including monetization of tax assets for growth companies and the employee retention tax credit; IGNITE American Innovation Act HR 7917; HEROES Act HR 6800; Tax bills to encourage American innovation and medical independence, HRs 7766, 7505, 7556; American Innovation and Jobs Act S. 4822
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Telecommunications TEC
Cybersecurity; data privacy issues; Net Neutrality; fintech; Emerging and foundational technologies rulemaking; antitrust and competition policy impacting startups
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Health Issues HCR
Drug pricing issues; proposals to create limited pathways for certain drugs; CMS reimbursement policy; Elijah E. Cummings Lower Drug Costs Now Act HR 3; Prescription Drug Pricing Reduction Act of 2019 S 2543
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY New | — |
| CHARLOTTE SAVERCOOL | — |
Small Business SMB
Small business issues; SBA 8(a) & 8(m) programs; SBIR/STTR programs, including proposals relating to venture capital ownership threshold for program eligibility; Small Business Innovation Voucher Act; Enhancing Entrepreneurship for the 21st Century Act, S. 2535; Issues related to the Coronavirus Aid, Relief, and Economic Security Act; Paycheck Protection Program (PPP)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Immigration IMM
Startup Act S. 328; Invest Visa; Entrepreneurial Visa; Executive Order on Immigration; Comprehensive Immigration Reform; International Entrepreneur Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Science/Technology SCI
Basic research funding and technology commercialization issues; H.R. 539/S. 118 Innovators to Entrepreneurs Act of 2019; Endless Frontier Act S. 3832/ H.R. 6978
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY FARRAH | — |
| JUSTIN FIELD | — |
| BOBBY FRANKLIN | — |
| JONAS MURPHY | — |
| CHARLOTTE SAVERCOOL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.